−70 KRW
1.66 B KRW
196.35 B KRW
14.57 M
About SAMIL PHARMACEUTICAL
Sector
Headquarters
Seoul
Founded
1947
Website
ISIN
KR7000520007
FIGI
BBG000BDQNM5
SAMIL PHARMACEUTICAL Co., Ltd. engages in the development and manufacture of pharmaceutical products. Its products include CNS Drugs, Ophthalmic Drugs, Respiratory Drugs, Genito-urinary Drugs, Antibiotics Chemotherapeutics, Circulatory Drugs, Gastro-Intestinal Drugs, Agents for Diabetes Mellitus, Hormones, Metabolic Drugs, Disinfectants, Amino Acids, Dental Preparations, Antipyretic, Allergy Drugs, Antihistamines, Analgesic, and Anti-inflammatory Agents. The company was founded on October 7, 1947 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 000520 is 12,840 KRW — it has decreased by −1.98% in the past 24 hours. Watch SAMIL PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange SAMIL PHARMACEUTICAL stocks are traded under the ticker 000520.
000520 stock has risen by 7.00% compared to the previous week, the month change is a −4.04% fall, over the last year SAMIL PHARMACEUTICAL has showed a 104.78% increase.
000520 reached its all-time high on Apr 10, 2018 with the price of 28,020 KRW, and its all-time low was 1,730 KRW and was reached on Jun 4, 2012. View more price dynamics on 000520 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
000520 stock is 3.63% volatile and has beta coefficient of 0.37. Track SAMIL PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is SAMIL PHARMACEUTICAL there?
Today SAMIL PHARMACEUTICAL has the market capitalization of 272.59 B, it has increased by 20.68% over the last week.
Yes, you can track SAMIL PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
000520 net income for the last quarter is −676.17 M KRW, while the quarter before that showed 350.31 M KRW of net income which accounts for −293.02% change. Track more SAMIL PHARMACEUTICAL financial stats to get the full picture.
As of Dec 21, 2024, the company has 568.00 employees. See our rating of the largest employees — is SAMIL PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAMIL PHARMACEUTICAL EBITDA is 10.75 B KRW, and current EBITDA margin is 6.02%. See more stats in SAMIL PHARMACEUTICAL financial statements.
Like other stocks, 000520 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAMIL PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SAMIL PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SAMIL PHARMACEUTICAL stock shows the buy signal. See more of SAMIL PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.